Ameritox

Rx Guardian CDSM

Rx Guardian CDSM is now part of the Rx GuardianSMprocess. Rx Guardian CDSM features a unique reference database of patients who were clinically assessed as adherent supported by a proprietary normalization algorithm. Your patients’ normalized results are compared against the reference database, giving you added confidence in assessing whether your patients are taking their medications correctly.

What is Rx Guardian CDSM?



  • Ameritox has created the next generation in pain medication monitoring solutions.
  • Rx Guardian CDSM consists of a proprietary algorithm and the most comprehensive reference database of pain patients who are clinically assessed as adherent, derived from more than one thousand actual chronic pain patients.
  • Patients in the database are clinically assessed and only patients identified as adherent are included in the reference database.
  • These patients’ urine drug levels are adjusted for certain physiologic variables, generating a normalized drug value, which then populates the reference Rx Guardian CDSM database.
  • Your patients’ normalized urine drug results can be compared against this dynamic database of pain patients.
  • This information can help you identify whether your patients are taking their medication correctly.
    • Patients whose normalized drug values exceed two standard scores from the reference database mean, accompanied by clinical indicators of risk (such as aberrant behaviors), may have a higher likelihood of drug abuse, misuse, or diversion.
    • Patients whose normalized drug values fall within two standard scores from the mean of the index database, and who lack clinical indicators of risk (such as aberrant behaviors), may have a lower likelihood of drug abuse, misuse, or diversion.
    For more information on Rx Guardian CDSM contact Ameritox today or learn more about the entire Rx GuardianSM process at rxguardian.ameritox.com.